INTRODUCTION The pharmaceutical industry is praised as one of the leading industrial sectors. The fruits of its extensive research and development are traded worldwide and have improved the length and quality of life of countless individuals. At the same time‚ however‚ the industry is criticized for its marketing and pricing practices—and even for its research and development priorities. Industry’s consistently high profits and large expenditures on research and development as well as on marketing
Premium Cost Supply and demand Economics
EXECUTIVE SUMMARY Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1 Trillion by 2013 The Pharmaceuticals Industry in India is the world’s 3 largest in terms of volume and stands 14th in terms of sale. Domestic pharma sector benefitted from increased thrust on Rural Health through bigger budgetary allocations in the Budget of 2009-10 According to PWC in 2010‚ India joined the league of Top 10 global pharmaceutical markets in terms of sales by 2020 with value reaching
Premium Pharmaceutical industry Generic drug
for the industry going forward? 1.Though the average level of profitability in the pharmaceutical industry has been declining over time (In 2002‚ the average ROIC in the industry was 21.6%; by 2006‚ it had fallen to 14.5%)‚ historically‚ the pharmaceutical industry has been a profitable one. Because- Name of industry | Average ROIC(Between 2002 and 2006) | Pharmaceuticals | 16.45%(large) | computer hardware | 12.76% | Electronics | 3.88% | 2. The prospect for the industry for going
Premium Pharmaceutical industry Pharmacology Generic drug
includes an external environmental analysis of Brazil’s pharmaceutical industry. The current pharmaceutical industry is still in its developing stage because the majority of pharmacological therapies made available to the public are either free or heavily subsidized by the government. The industry is also affected by a number of new regulations such as the National Drug Control System and Registration requirements for Active Pharmaceutical Ingredients (APIs) in November 2009‚ and new labelling &
Premium Pharmacology Medicine Economics
Organizational Structure in the Pharmaceuticals Industry Abstract Pfizer and Johnson & Johnson are the largest and most successful pharmaceutical companies in the world today. Each company has a massive workforce and conducts business in countries all over the globe. Both companies have used a high degree of horizontal differentiation in order to manage their business units more effectively. Operating companies are grouped together by their function‚ as well as the type of product the
Premium Management Fortune 500 Globalization
Pharma billionaire arrested for bribing doctors to prescribe opioid painkillers (-- removed HTML --) The pharmaceutical industry needs people to keep getting sick and they need new diseases to infect the human population. They need these things because they need to keep making money. The pharmaceutical industry is worth billions of dollars and no one wants to lose any money. That’s why‚ even though there’s an opioid crisis that kills tens of thousands of people a year and was originally declared
Premium
Introduction The Holland Sweetener Company (HSC) is planning to enter the low-calorie‚ high-intensity sweetener market which is currently dominated by NutraSweet. Below we first analyze our target industry. Next we look at what kind of response should HSC expect from NutraSweet upon its entry into this market. We will also analyze few likely scenarios that could play out and we will try to estimate the likelihood of each scenario. Based on our analysis‚ we will give a recommendation for HSC to
Premium Coca-Cola Soft drink Pepsi
1. Drawing on the five forces model‚ explain why the pharmaceutical industry has historically been a very profitable? a. Rivalry among competing firms i. Patent protected medicine allows prating monopoly ii. In pharmaceutical industry they have several strong competition compete again few rather than more companies b. Threat of substitute product i. Very costly to introduce a new drugs ii. So many medicines protect by patent law‚ all competitors can make countertrend drugs who have almost
Premium Pharmacology Pharmaceutical industry Generic drug
Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
| Ethics in Corporate Society | | PHARMACEUTICAL MARKETING-the growing ethical concern? Analytical Report | | | Madiha Raza Noama Naeem Sheikh Zargham Zaigham LETTER OF AUTHORIZATION November 5‚ 2011 Dear Readers‚ As students of BBA‚ our course instructor of Ethics in Corporate Society‚ Ms. Tania Danish authorized us to make a report on the “PHARMACEUTICAL MARKETING-the growing ethical concern?” We were required to make a report in accordance to our learning in the course
Premium Pharmacology Pharmaceutical industry Pharmacy